Farmacosmo S.p.A. (BIT:COSMO)
Italy · Delayed Price · Currency is EUR 0.4180
+0.0060 (1.46%)
At close: Oct 16, 2026
Farmacosmo Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 42.54 | 51.98 | 63 | 71.21 | 65.66 | 58.02 |
Other Revenue | 3.69 | 3.67 | 0.41 | 0.36 | 0.16 | 0.12 |
| 46.23 | 55.65 | 63.41 | 71.57 | 65.82 | 58.15 | |
Revenue Growth | -21.19% | -12.23% | -11.40% | 8.74% | 13.19% | 31.88% |
Cost of Revenue | 48.14 | 58.56 | 63.1 | 72.04 | 66.42 | 56.67 |
Gross Profit | -1.91 | -2.9 | 0.31 | -0.47 | -0.61 | 1.48 |
Selling, General & Admin | 0.31 | 0.35 | 0.36 | 0.53 | 0.17 | 0.13 |
Amortization of Goodwill & Intangibles | 2.56 | 2.58 | 2.56 | 2.72 | 1.38 | 0.38 |
Other Operating Expenses | 0.02 | -0.22 | -0.4 | -0.59 | -0.67 | -0.2 |
Operating Expenses | 2.95 | 2.78 | 2.59 | 2.77 | 1.04 | 0.41 |
Operating Income | -4.87 | -5.68 | -2.28 | -3.24 | -1.65 | 1.07 |
Interest Expense | -1.14 | -1.25 | -1.2 | -0.95 | -0.55 | - |
Interest & Investment Income | 3.8 | 3.38 | 0.38 | 0.01 | - | - |
Currency Exchange Gain (Loss) | 0 | 0 | -0 | -0 | - | -0 |
Other Non Operating Income (Expenses) | -0 | -0 | 0 | 0 | 0.04 | -0.4 |
Pretax Income | -2.21 | -3.54 | -3.1 | -4.18 | -2.16 | 0.66 |
Income Tax Expense | 0.37 | 1.06 | -0.03 | -0.25 | -0.15 | 0.25 |
Earnings From Continuing Operations | -2.58 | -4.6 | -3.07 | -3.93 | -2 | 0.41 |
Net Income to Company | - | -4.6 | -3.07 | -3.93 | -2 | 0.41 |
Minority Interest in Earnings | 0.24 | 0.17 | 0.1 | 0.7 | 0.67 | - |
Net Income | -2.34 | -4.43 | -2.97 | -3.23 | -1.34 | 0.41 |
Net Income to Common | -2.34 | -4.43 | -2.97 | -3.23 | -1.34 | 0.41 |
Net Income Growth | - | - | - | - | - | 10.90% |
Shares Outstanding (Basic) | 39 | 39 | 39 | 39 | - | 30 |
Shares Outstanding (Diluted) | 39 | 39 | 39 | 39 | - | 30 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -0.06 | -0.11 | -0.08 | -0.08 | - | 0.01 |
EPS (Diluted) | -0.06 | -0.11 | -0.08 | -0.08 | - | 0.01 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2.45 | 0.53 | -2.18 | -5.29 | - | -0.43 |
Free Cash Flow Per Share | 0.06 | 0.01 | -0.06 | -0.14 | - | -0.01 |
Dividend Per Share | - | - | - | - | - | 0.010 |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | -4.14% | -5.21% | 0.49% | -0.66% | -0.92% | 2.54% |
Operating Margin | -10.52% | -10.20% | -3.60% | -4.53% | -2.50% | 1.83% |
Profit Margin | -5.07% | -7.96% | -4.69% | -4.52% | -2.03% | 0.71% |
Free Cash Flow Margin | 5.30% | 0.95% | -3.44% | -7.39% | - | -0.73% |
EBITDA | -4.03 | -4.21 | 0.35 | -0.42 | -1.37 | 1.34 |
EBITDA Margin | -8.72% | -7.56% | 0.55% | -0.58% | -2.08% | 2.31% |
D&A For EBITDA | 0.84 | 1.47 | 2.63 | 2.83 | 0.28 | 0.28 |
EBIT | -4.87 | -5.68 | -2.28 | -3.24 | -1.65 | 1.07 |
EBIT Margin | -10.52% | -10.20% | -3.60% | -4.53% | -2.50% | 1.83% |
Effective Tax Rate | - | - | - | - | - | 37.30% |
Revenue as Reported | 46.74 | 56.26 | 64.26 | 72.61 | 66.64 | 58.5 |